...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma
【24h】

Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma

机译:局部晚期胰腺癌联合化疗和中度超分割旋转放射治疗后毒性的剂量学和临床预测指标

获取原文
获取原文并翻译 | 示例

摘要

Background and purpose Hypofractionated radiotherapy (RT) of pancreatic adenocarcinoma is limited by the tolerance of adjacent normal tissues. A better understanding of the influence of dosimetric variables on the rate of toxicity after RT must be considered an important goal. Methods and materials Sixty-one patients with histologically proven locally advanced disease (LAPD) were analyzed. The therapeutic strategy consisted of induction chemotherapy (ChT) followed by concurrent chemoradiotherapy (CRT). In 39 out of 61 patients the target volume was based on a four-dimensional CT (4D-CT) procedure. Delivered dose was 44.25 Gy in 15 fractions to PTV2, which consisted of pancreatic tumor and regional lymph nodes considered radiologically involved; 23 out of 61 patients received a simultaneous integrated boost (SIB) to a tumor sub-volume infiltrating the great abdominal vessels (PTV1) with dose in the range of 48-58 Gy. RT was delivered with Helical Tomotherapy. Dose-volume histograms (DVHs) of target volumes and organs at risk (OARs) were collected for analysis. The predictive value of clinical/dosimetric parameters was tested by univariate/multivariate analyses. Results The crude incidence of acute gastrointestinal (GI) grade 2 toxicity was 33%. The 12-month actuarial rate of "anatomical" (gastro-duodenal mucosa damage) toxicity was 13% (95% CI: 4-22%). On univariate analysis, several stomach and duodenum DVH endpoints are predictive of toxicity after moderately hypofractionated radiotherapy. Multivariate analysis confirmed that baseline performance status and the stomach V20[%] were strong independent predictors of acute GI grade ≥2 toxicity. The high-dose region of duodenum DVH (V45[%]; V 40[%]) was strongly correlated with grade ≥2 " anatomical" toxicity; the best V40[%] and V45[%] cut-off values were 16% and 2.6% respectively. Conclusion Regarding dosimetric indices, stomach V20[%] correlates with a higher rate of acute toxicity; more severe acute and late anatomical toxicities are related to the high dose region of duodenum DVH.
机译:背景和目的胰腺腺癌的超分割放疗(RT)受邻近正常组织的耐受性限制。必须更好地理解剂量参数对放疗后毒性反应速率的影响,这是一个重要的目标。方法和材料对61例经组织学证实为局部晚期疾病(LAPD)的患者进行了分析。治疗策略包括诱导化疗(ChT),然后同步放化疗(CRT)。 61例患者中有39例的目标量是基于三维CT(4D-CT)程序的。 PTV2的分装剂量为15分之44.25 Gy,由胰腺肿瘤和经放射学考虑的局部淋巴结组成。 61例患者中有23例同时接受了整合的升压(SIB)治疗,肿瘤扩散至大腹部血管(PTV1)的肿瘤子体积范围为48-58 Gy。 RT与Helical Tomotherapy一起提供。收集目标体积和处于危险状态的器官(OAR)的剂量体积直方图(DVH)进行分析。临床/剂量参数的预测价值通过单因素/多因素分析进行​​了检验。结果急性胃肠道(GI)2级毒性的发生率约为33%。 “解剖”(胃-十二指肠粘膜损伤)毒性的12个月精算率为13%(95%CI:4-22%)。单因素分析显示,胃和十二指肠DVH的几个终点可预测中度次分割放疗后的毒性。多因素分析证实,基线表现状态和胃V20 [%]是急性GI级≥2毒性的强独立预测因子。十二指肠DVH的高剂量区域(V45 [%]; V 40 [%])与≥2级“解剖”毒性密切相关;最佳V40 [%]和V45 [%]截止值分别为16%和2.6%。结论在剂量学指标上,胃中的V20 [%]与较高的急性毒性相关。十二指肠DVH的高剂量区域与更严重的急性和晚期解剖毒性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号